Methylmercury and long chain polyunsaturated fatty acids are associated with immune dysregulation in young adults from the Seychelles child development study. by McSorley, Emeir M. et al.
Journal Pre-proof
Methylmercury and long chain polyunsaturated fatty acids are associated with
immune dysregulation in young adults from the Seychelles child development study.
Emeir M. McSorley, Edwin van Wijngaarden, Alison J. Yeates, Toni Spence, Maria
S. Mulhern, Donald Harrington, Sally W. Thurston, Tanzy Love, Todd A. Jusko, Philip
J. Allsopp, Marie C. Conway, Philip W. Davidson, Gary J. Myers, Gene E. Watson,




To appear in: Environmental Research
Received Date: 3 October 2019
Revised Date: 20 December 2019
Accepted Date: 20 December 2019
Please cite this article as: McSorley, E.M., van Wijngaarden, E., Yeates, A.J., Spence, T., Mulhern,
M.S., Harrington, D., Thurston, S.W., Love, T., Jusko, T.A., Allsopp, P.J., Conway, M.C., Davidson,
P.W., Myers, G.J., Watson, G.E., Shamlaye, C.F., Strain, J.J., Methylmercury and long chain
polyunsaturated fatty acids are associated with immune dysregulation in young adults from the
Seychelles child development study., Environmental Research (2020), doi: https://doi.org/10.1016/
j.envres.2019.109072.
This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition
of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of
record. This version will undergo additional copyediting, typesetting and review before it is published
in its final form, but we are providing this version to give early visibility of the article. Please note that,
during the production process, errors may be discovered which could affect the content, and all legal
disclaimers that apply to the journal pertain.
© 2019 Published by Elsevier Inc.
Manuscript Title 
Methylmercury and long chain polyunsaturated fatty acids are associated with immune 
dysregulation in young adults from the Seychelles Child Development Study.  
 
Authors 
Emeir M McSorley1, Edwin van Wijngaarden2, Alison J Yeates1, Toni Spence1, Maria S 
Mulhern1, Donald Harrington2, Sally W Thurston2, Tanzy Love, Todd A Jusko2, Philip J 
Allsopp1, Marie C Conway1, Philip W Davidson2, Gary J Myers2, Gene E Watson2, Conrad F 
Shamlaye3 and JJ Strain1 
 
Authors Institutional Affiliations 
From 1the Nutrition Innovation Centre for Food and Health (NICHE), School of Biomedical 
Sciences, Ulster University, Coleraine, Northern Ireland (EMM, AJY, TS, MSM, PJA, MCC, 
JJS); 2the School of Medicine and Dentistry, University of Rochester, NY, United States 
(EvW, DH, SWT, TL, TJ, PWD, GJM, GEW) and 3the Child Development Centre, Ministry of 
Health, Mahé, Republic of Seychelles (CFS). 
 
Corresponding Author:  
Dr Emeir M McSorley, Nutrition Innovation Centre for Food and Health (NICHE), School of 
Biomedical Sciences, Ulster University, Coleraine, Northern Ireland. E-mail: 
em.mcsorley@ulster.ac.uk Tel: +44 (0)28 70123543 
 
Funding sources 
This research was supported by grants R01-ES008442, R03-ES027514, and P30-ES01247, 
from the United States National Institute of Environmental Health Sciences (National 
Institutes of Health) and in-kind by the Government of the Republic of Seychelles. The study 
sponsors had no role in the design, collection, analysis, or interpretation of the data; in the 
writing of the report; or in the decision to submit the article for publication. The authors 








BACKGROUND: Exposure to the environmental toxicant mercury (Hg) has been associated 
with immune dysregulation, including autoimmune disease, but few human studies have 
examined methylmercury (MeHg) exposure from fish consumption.  
OBJECTIVES: We examined associations between MeHg exposure and biological markers 
of autoimmunity and inflammation while adjusting for long chain polyunsaturated fatty acids 
(LCPUFA). 
METHOD: At age 19 years, hair total Hg (Y19Hg), LCPUFA status, a panel of 13 antinuclear 
antibodies (ANA), total serum immunoglobulins (Ig) IgG, IgA, and IgM and serum markers of 
inflammation (IL-1, IL-2, IL-6, IL-10, C-reactive protein (CRP), IFN-γ, TNF-α) were measured 
in the Seychelles Child Development Study (SCDS) Main Cohort (n=497). Multivariable 
regression models investigated the association between Y19Hg and biomarkers, adjusting 
for prenatal total hair Hg (MatHg) and other relevant covariates, and with and without 
adjustment for LCPUFA.  
RESULTS:  With each 1 ppm increase in Y19Hg (mean 10.23 (SD 6.02) ppm) we observed 
a 4% increased odds in a positive Combined ANA following adjustment for the n6:n3 
LCPUFA ratio (β = 0.036, 95%; CI: 0.001, 0.073). IgM was negatively associated with 
Y19Hg (β = -0.016, 95%CI: -0.016, -0.002) in models adjusted for n-3, n-6 LCPUFA and 
when separately adjusted for the n-6:n-3 LCPUFA ratio. No associations were observed with 
MatHg. Total n-3 LCPUFA status was associated with reduced odds of a positive anti-
ribonuclear protein (RNP) A. The n-3 LCPUFA were negatively associated with IL-6, IL-10, 
CRP, IFN-γ, TNF-α and positively with TNF-α:IL-10. There were positive associations 
between the n-6:n-3 ratio and IL-6, IL-10, CRP, IFN-γ, TNF-α and a negative association 
with TNF-α:IL-10.  
DISCUSSION:  
The Y19Hg exposure was associated with higher ANA and lower IgM albeit only following 
adjustment for the n-3 LCPUFA or the n-6:n-3 LCPUFA ratio. The clinical significance of 
these findings is unclear, but warrant follow up at an older age to determine any relationship 
to the onset of autoimmune disease.  
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Introduction 
Exposure to the ubiquitous environmental toxicant mercury (Hg) has been associated with 
immune dysregulation including autoimmune disease (Blossom & Gilbert, 2018). It is 
proposed that Hg exposure, in combination with genetic predisposition, may result in 
autoimmune disease development or exacerbation (Silbergeld et al., 2005), albeit nearly all 
this evidence is derived from experimental animal studies with inorganic Hg exposure and 
evidence from human studies is lacking (Crowe et al., 2017; Bjorklund et al., 2017). Humans 
are primarily exposed to organic Hg following consumption of fish, which bio-accumulate 
organic methylmercury (MeHg) from their environment. If Hg is associated with autoimmune 
disease in people, it would be a major public health concern as fish are an important source 
of protein in many populations globally. 
Immunotoxic effects of Hg have been observed in murine models where exposure to Hg 
(either organic or inorganic) results in the expression of autoimmune markers including anti-
nuclear antibodies (ANA), anti-nucleolar antibodies (ANoA) and anti-chromatin (ACA); 
(Crowe et al., 2017; Pollard et al., 2019). In humans, several studies investigating 
occupational Hg exposure in artisanal gold mining communities have reported elevated titres 
of ANA and ANoA along with elevated concentrations of inflammatory markers (Il-1β, TNF-α 
and IFN-γ) (Silva et al., 2004; Alves et al., 2006; Nyland et al., 2011; Motts et al., 2014). 
Others, however, have observed no association between Hg and biomarkers of immune 
dysfunction (Barregard et al., 1997; Ellingsen et al., 2000; Alves et al., 2006; Sánchez 
Rodríguez et al., 2015). Analysis of the U.S. National Health and Nutrition Examination 
Survey (NHANES) data has identified associations, in women, between higher blood Hg 
concentrations and ANA positivity (Somers et al., 2015) as well as between Hg and higher 
concentrations of thyroid autoantibodies (Gallagher and Meliker, 2018). In a high fish 
consuming cohort from the Amazonian region, MeHg exposure was associated with higher 
IL-6, IFN-γ, IL-4 and IL-17 cytokine concentrations (Nyland et al., 2011), but other studies 
have observed no association (Monastero et al., 2017). The majority of research to-date has 
investigated concurrent Hg exposure with one study reporting an inverse association 
between prenatal MeHg exposure at 28 weeks gestation and immune markers (McSorley et 
al., 2018). 
Associations between markers of autoimmunity and MeHg exposure in populations with high 
fish consumption have not been widely investigated.  An examination of prenatal and 
postnatal MeHg exposure and total serum IgG and IgM concentrations in a fish-eating cohort 
from the Faroe Islands reported significant associations with postnatal MeHg exposure at 
age 7 years and both IgG and IgM concentrations (Osuna et al., 2014). Conflicting with this 
finding, no association was observed between concurrent MeHg and markers of 
autoimmunity within a seafood consuming population from Long Island, New York 
(Monastero et al., 2017). Overall, the interpretation of existing research is hampered by 
differences in sources of MeHg exposure, varying sample size and the presence in some 
studies of malaria which affects immunity (Sánchez Rodríguez et al., 2015). Thus, large 
population based studies are required to fully elucidate any potential impact of Hg exposure, 
particularly that of MeHg from fish consumption, in the development of autoimmune disease 
(Pollard et al., 2010). Adding to the complexity, fish are a rich source of the long chain 
polyunsaturated fatty acids (LCPUFA), predominately n-3 LCPUFA, which have anti-
inflammatory properties and are associated with a reduction of circulating inflammatory 
markers (Calder, 2015). Therefore, when investigating immunotoxic effects of MeHg, 
research should also consider the potential beneficial effects of LCPUFA on immune 
function.  
The fish-eating cohort of 19 year olds from the Seychelles Child Development Study (SCDS) 
have an average consumption of 7 fish meals per week and a MeHg exposure 
approximately 10 times the levels in the United States (van Wijngaarden et al., 2017). Using 
this cohort, we investigated whether MeHg exposure from fish consumption (prenatal and 
concurrent exposure) was associated with markers of autoimmunity and inflammation. It was 
hypothesised that both prenatal and concurrent MeHg exposure would be associated with 





The SCDS enrolled 779 pregnant women during 1989-1990 as the ‘Main cohort’ to 
investigate associations between prenatal MeHg exposure and child neurodevelopment. At 
the 6-month time point, data for 39 mother-child pairs were excluded owing to mother’s 
illness during pregnancy, insufficient maternal hair to recapitulate prenatal MeHg exposure, 
twin births or children born with conditions known to affect neurodevelopment (e.g. 
prematurity, severe perinatal illness, closed head trauma with loss of consciousness, 
encephalitis or meningitis). Subsequent exclusions through age 19 years for epilepsy, head 
trauma or meningitis resulted in the removal of 56 additional participants leaving a total of 
684 participants at 19 years of age for analysis. 
A total of 530 serum samples from the participants at 19 years were collected and stored at -
80°. Data for 497 participants’ immune markers were  used in the present study owing to 
inadequate serum volume for analysis in 29 samples and 4 specimens of immune markers 
could not be matched with study ID numbers. The study protocol was reviewed and 
approved by the Seychelles Ethics Board and the Research Subjects Review Board at the 
University of Rochester.  
 
Immunology testing 
Stored serum samples were thawed and analysed at Ulster University. Inflammatory 
cytokines were measured using the electrochemiluminescence based Meso Scale Discovery 
(MSD) multiplex assay (Meso Scale Diagnostics, LLC.) and included interleukin (IL)-1β, IL-2, 
IL-6, IL-10, interferon-gamma (IFN-γ) and tumour necrosis factor-alpha (TNF-α). All 
cytokines are reported in pg/ml. Inter and intra assay cytokine CVs were IL-1β (28.61%; 
<28%), IL-2 (30.67%; <24%), IL-6 (25.81%; <23%) , IL-10 (23.1%; <33%), IFN-γ 
(21.87%;<32%) and TNF-α (12.11%; <20%). CRP (mg/L), a marker of acute inflammation, 
was measured by an ultra‐sensitive diagnostic kit (Werfen Ltd. England) using the iLab 650 
Clinical Chemistry Analyzer and had an inter-assay CV of 16.37% and an intra assay CV of 
<12%. Cytokine measurements below the lower limited of detection (LLOD), as determined 
by the standard curve for each cytokine individually, was assigned a value of LOD/√2 for 
statistical analysis. Serum immunoglobulin-A (IgA), IgG and IgM (g/L) were measured by 
ELISA (Thermo Fisher, UK) at the Immunology Laboratory, Royal Victoria Hospital Belfast.  
ANA status was screened for using the BioPlex ANA fully automated multiplex system 
(BioRad, UK) which has good concordance with comparative methods (Sohn & Khan, 2014). 
Screening of the samples by indirect immunofluorescence characterized the presence or 
absence of specific antinuclear antibodies (ANA). All samples were analysed for the 
quantitative detection of anti-dsDNA and the semi-quantification in antibody of anti-ribosomal 
P, anti-chromatin, anti-Ro52, anti-Ro60, anti-La, anti-Sm, anti Sm/RNP, anti-RNP A, anti-
RNP 68, anti-Scl-70, anti-Jo-1 and anti-centromere B. The ANA screen is reported as 
negative if the results for all 13 autoantibodies are negative. Conversely, if any of the 13 
autoantibodies is positive, we report a positive ANA screen and the Antibody Index (AI) of 
individual antibodies. The AI is an arbitrary unit defined by the manufacturer when no official 
standards are available. Anti-dsDNA antibody is calibrated against World Health 
Organization Wo/80 standard and expressed in terms of IU/mL with values ≥4 IU/mL 
reported as positive. All other antibody results are semi-quantitative, expressed in terms of 
AI, and values ≥1.0 AI are taken as positive.  
Methylmercury exposure 
Prenatal MeHg exposure was determined using maternal hair samples collected either 
during pregnancy, at delivery, or at the 6-month enrolment (Myers et al., 1995). MatHg was 
measured as total Hg from these hair samples by cold vapour atomic absorption 
spectroscopy where the closest centimetre to the scalp represents the most recent exposure 
of one month. Concurrent postnatal exposure at 19 years of age (Y19Hg) was measured 
using the same approach in a 1 cm length of each participant's hair taken at time of testing. 
All Hg results are presented as MeHg are total Hg (THg) based on the assumption that 
~80% of THg in hair is MeHg within the Seychelles population (Cernichiaria et al., 1995).  
Fatty acid analysis 
Plasma phospholipids were measured at 19 years as outlined previously (van Wijngaarden 
et al., 2013). In brief, total lipids were extracted from plasma samples, using a modified 
method of Folch et al., (1957). A solid phase extraction using an NH2 cartridge system 
conditioned with chloroform and followed by a series of solvent elution’s was used to isolate 
phospholipids. Absolute amounts of LCPUFA were determined using gas chromatography 
mass spectrometry (GCMS) as described previously (Bonham et al., 2008) and included 
linoleic acid (LA, C18:2 n-6), α-linolenic acid (ALA, C18:3 n-3), arachidonic acid (AA, C20:4 
n-6), eicosapentaenoic acid (EPA, C20:5 n-3) and docosahexaenoic acid (DHA, C22:6 n-3). 
Results were presented as mg/mL to indicate physiologic quantities. Total n-6 (mg/ml) was 
calculated by the addition of LA and AA concentrations, and ALA, EPA and DHA were 
summed to calculate total n-3 (mg/ml). The n-6:n-3 ratio was calculated.  
Statistical analysis 
Descriptive statistics summarised the distributions of MeHg, serum cytokines, 
immunoglobulins, autoantibodies and covariates. Cytokine and immunoglobulin 
measurements were log transformed for the linear regression models as these measures 
were extremely right skewed. Clinically elevated concentrations of individual ANA markers 
were uncommon, perhaps because of the relatively young age of the 19-year study 
participants. For 11 of the 13 ANA markers, >95% of the ANA values were below the LLOD. 
Therefore, these ANA variables were not analyzed as individual markers.  Instead, we 
designed a combined dichotomous ANA variable called ‘Combined ANA’ that was calculated 
based on being within or above reference range for one of more of the 13 measured ANA 
markers. Some 56% of the subjects met this criterion. In addition, because of their larger 
number of measurable values, Anti-dsDNA and Anti-RNP A were analyzed as both 
dichotomous (<LOD or LOD+) and categorical (<LOD, LOD-ref, >ref) individual markers.   
Associations between serum cytokines, immunoglobulins, autoantibodies and pre- and 
postnatal MeHg exposure were examined through linear (cytokines and immunoglobulins) 
and logistic (autoantibodies) regression models. Covariates, known or suspected to be 
associated with (subclinical) autoimmunity or inflammation, included in the analysis were 
maternal age, child sex, socioeconomic status (SES) and obesity. Maternal socioeconomic 
status was measured using the Hollingshead Social Status Index modified for the use of 
employment codes relevant to the Republic of Seychelles (Davidson et al., 1998; Kobrosly et 
al., 2011). Models that included MatHg adjusted for maternal age at birth, maternal 
socioeconomic status (SES) and child sex. Models that included postnatal Y19Hg adjusted 
for child sex and waist circumference (WC) at 19 years as a proxy for abdominal obesity. 
Consistent with previous cross-sectional analyses of postnatal exposure in the SCDS (van 
Wijngaarden et al., 2013), postnatal Hg models also adjusted for prenatal MeHg exposure 
measured in maternal hair. We additionally controlled for 19-year LCPUFA status in 
separate models to evaluate the possibility that adverse associations may be missed or 
underestimated due to uncontrolled confounding by the immunomodulatory effect of 
LCPUFA. In separate models we also included interactions of child sex with both MatHg and 
Y19Hg to assess whether males or females are more susceptible to the effects of MeHg 
exposure. Following analysis, we found no evidence for interactions; therefore, we report 
results from the corresponding models without this interaction.  
All statistical analyses were performed using R, Version 3.5.1. Statistical significance in all 
analyses was determined using a two-sided approach α=0.05. Regression model 
assumptions were checked using standard methods (Weisberg 2005). If violated, we 
consider transforming the outcome or fitting nonlinear additive models (Hastie and Tibshirani 
1990). Results were evaluated for extreme outliers and unduly influential points. All values 
presented in tables are log transformed.  
 
Results  
Year 19 demographic characteristics for participants are displayed in Table 1. Immune 
markers for a total of 497 mother-child pairs were analysed, consisting of 268 females and 
229 males. Mean (SD) MatHg and Y19Hg was 6.84 (4.55) and 10.23 (6.02) ppm, 
respectively. An average (SD) of 7.22 (3.66) fish meals per week were consumed by 
participants who had a mean (SD) n-6:n-3 LCPUFA ratio of 3.81 (1.97). 
 
MeHg, LCPUFA, and anti-nuclear antibodies 
Regression analyses for covariate adjusted associations between MeHg exposure and 
immunologic markers are presented in Table 2. The Y19Hg was significantly associated with 
a higher Combined ANA (β = 0.036, 95%; CI: 0.001, 0.073) where for each 1 ppm increase 
in Y19Hg we observed a 4% increased odds for a positive Combined ANA following 
adjustment for the n-6:n-3 LCPUFA ratio. MatHg was not significantly associated with a 
change in odds for a positive Combined ANA. Separately, a significant association was 
observed between the anti-RNP A and n-3 LCPUFA (Table 3). No significant association 
was found between n-6 LCPUFA and ANA or any immune marker. 
 
MeHg, LCPUFA, and immunoglobulins (Ig) 
Y19Hg was negatively associated with IgM in the models adjusted for n-3 LCPUFA (β = -
0.009, 95%CI: -0.016, -0.002) and when separately adjusted for the n6:n3 LCPUFA ratio (β 
= -0.009, 95%CI: -0.016, -0.001) (Table 2). MatHg was not associated with any Ig. None of 
the MeHg metrics were associated with IgA. No significant associations were found with n-3 
LCPUFA, n-6 LCPUFA and the n6:n3 LCPUFA ratio and IgG.  
 
MeHg, LCPUFA, and cytokines and CRP 
Significant positive associations were observed between Y19Hg and CRP in the models that 
adjusted for n-3 and n-6 LCPUFA (β = 0.031, 95%CI:0.007, 0.054) and the n-3:n-6 ratio (β = 
0.031, 95%CI:0.007, 0.054) (Table 2). Y19Hg was significantly associated with IL-10 in the 
model that adjusted for n-3 and n-6 LCPUFA (β = 0.016, 95%CI:0.002, 0.030) and in the 
model which adjusted for the n-3:n-6 ratio (β = 0.016, 95%CI:0.002, 0.031). A statistically 
significant association was observed between Y19Hg and the TNFα:IL-10 ratio in the model 
adjusted for n-3 and n-6 LCPUFA (β = -0.016, 95%CI: -0.027, -0.005) and in the model 
which adjusted for the n-3:n-6 LCPUFA ratio (β = -0.016, 95%CI: -0.027, -0.005). MatHg was 
not associated with any of the measured cytokines or CRP. 
There were significant negative associations between n-3 LCPUFA and CRP, IFN-γ, TNF-α, 
IL-6 and IL-10 (Table 3). A positive association was observed between n-3 LCPUFA and the 
TNFα:IL-10 ratio. Statistically significant positive associations were found between the n-6:n-
3 ratio and CRP, IFN-γ, TNF-α, IL-6 and IL-10 and a significant negative association with the 




Females had significantly greater levels of Combined ANA, anti-dsDNA, CRP and IgM in all 
models. Female had significantly lower levels of TNF-α in all models. Higher levels of 
maternal SES was significantly associated with increased IgA concentrations without 
adjustment for LCPUFA (β = 0.003, p = 0.006). Larger values of Year 19 WC was 
significantly associated with positive IL-6 concentrations (β = 0.022, p < 0.0001) and positive 
CRP concentrations (β = 0.047, p < 0.0001) in all models.   
 
Discussion 
Evidence from animal models suggests a potential link between Hg exposure and the 
pathogenesis of autoimmune disease. Less, however, is known in human populations 
especially with respect to MeHg exposure through fish consumption. In this high fish-eating 
population from the SCDS, we found that current MeHg exposure at 19-year of age was 
associated with a novel measure of ANA (Combined ANA) but only following adjustment for 
the n-6:n-3 LCPUFA ratio. Furthermore, Y19Hg was associated with lower IgM, higher CRP, 
higher IL10 and a lower TNFα:IL10 ratio. Prenatal Hg exposure was not associated with any 
specific marker of ANA, cytokines or Ig. Although current MeHg exposure at 19 years was 
associated with higher odds of having a higher ANA combined score the clinical significance 
of these findings is unclear and further research is warranted to determine if these 
associations precede autoimmune disease development. Total n-3 LCPUFA was associated 
with lower anti-RNP A, ANA and overall a more anti-inflammatory profile supporting the well-
known benefits of n-3 LCPUFA in regulating the immune system (Calder et al., 2015).  
In this cohort, hair Hg concentrations were on average 10 times those reported from the 
USA (Davidson et al., 1998; Myers et al., 2003; van Wijngaarden et al., 2017). At 19 years, 
this cohort reported an average consumption of 7 fish meals per week which correlated with 
Hg supporting the evidence that fish consumption is a significant predictor of MeHg 
exposure in humans (Schober et al., 2003; Clark et al., 2007; Bjermo et al., 2013; Somers et 
al., 2015). The higher exposure of Hg in the 19 year olds may, in part, explain why the 
associations between MeHg and ANA were only evident at this time point following 
adjustment for the n6:n3 LCPUFA ratio. It is also plausible that the measure of MeHg 
exposure at 19 years reflects better than MatHg exposure what is happening systemically in 
the blood sample taken at the same timepoint.  
Previous research by our group has emphasised the importance of n-3 LCPUFA, obtained 
primarily in the diet through fish consumption, in mitigating any potential effects of MeHg 
(Strain et al., 2015; Strain et al., 2008). The National Health and Nutrition Examination 
Survey (NHANES) investigated young females with hair Hg of 0.22ppm and blood Hg of 
0.944 ug/L and, similar to our results, reported associations between ANA positivity and a 
high titre of ANA positively in models which also adjusted for n-3 LCPUFA (Somers et al., 
2015). Associations between Hg exposure and ANA have been reported in gold mining 
communities (Aves et al., 2006, Gardner et al., 2010) and to a lesser extent in a high fish-
eating riverine community in Amazonian Brazil (Silva et al., 2004, Nyland et al., 2011). 
Within these studies, malaria infections are suggested to add to the strength of the 
association between Hg exposure and ANA. Furthermore, exposure to Hg is associated with 
dysregulation of inflammatory cytokines and cellular oxidative stress proteins which authors 
suggest contributes to the immunotoxicity of Hg (Motts et al., 2014).  Contrary to these 
findings, analysis in an American Sioux Tribe, who regularly consume fish from a river 
known to be ubiquitously contaminated with Hg showed that some 30% of individuals were 
positive for ANA, however there was no overall association between blood Hg values and 
ANA (Ong et al., 2014). Within their analysis these workers did not adjust for n-3 LCPUFA 
which may have negatively confounded any associations with Hg (Budtz-Jorgensen et al., 
2007). Similarity, in a gold mining population in the Andes, Columbia, no difference in ANA 
status was observed between those exposed to Hg compared to those not exposed 
(Sanchez-Rodriguez et al., 2015). Whilst they did adjust for estimated Hg intake from fish 
consumption it would have been interesting to see if adjustment for biological status of n-3 
LCPUFA would have revealed an association given that there was a higher consumption of 
fish in those exposed to Hg compared to the non-exposed group. A pilot study of a fish-
eating cohort from Long Island, USA also found no association between Hg and the 
expression of genes known to be involved in autoimmunity; however, they reported, owing to 
small sample size, that they did not control for n-3 LCPUFA in the analysis. Taken together, 
those studies that have investigated MeHg exposure from fish consumption, and have not 
adjusted for n-3 LCPUFA in the statistical models, have found no associations with markers 
of autoimmunity whereas those that have controlled for n-3 LCPUFA have reported 
associations, albeit the magnitude of effect appears to be related to the source of Hg (gold 
mining or from fish consumption) as well as other confounders including infections. The 
Seychelles population is not affected by malaria and has a primary route of MeHg exposure 
through fish consumption; therefore, the findings reported here support the existing literature 
that the benefits of LCPUFA from fish consumption outweigh any adverse effect of MeHg on 
health outcomes including autoimmunity.  
The focus of this paper is MeHg exposure through fish consumption. Nevertheless, it is 
important to recognise that research to date, in murine models, has shown a stronger 
association between inorganic Hg exposure and the development of autoimmune type 
responses (Crowe et al., 2018).  Differences in intracellular diffusion and biodistribution of 
the two forms of Hg may explain why inorganic Hg is more strongly associated with the 
development of autoimmunity (Bjorklund et al., 2017; Pollard et al., 2019). MeHg is proposed 
to have a delayed and less inflammatory response without the development of immune 
complexes whereas inorganic Hg is associated with renal damage (Crowe et al., 2017).  
The exact mechanisms involved in Hg-associated autoimmunity remains elusive with some 
suggestions that Hg may contribute to the stimulation and survival of autoreactive immune 
cells due to its ability to disrupt self-antigen presentation, functional B-cell signalling, 
effective class switching and the deletion of autoreactive immune cell clones (Crowe et al., 
2017; Khan & Wang,  2018; Pollard et al, 2018). Hg may also contribute to the stimulation of 
an autoimmune response due to its ability to simulate the innate and adaptive response 
(Pollard et al, 2018). One potential mechanism by which Hg exposure could lead to 
autoimmunity is through Hg induced tissue damage resulting in the release of damage 
associated molecular patterns (DAMPs) and/or modified DAMPs with the subsequent 
activation of a local innate immune response alongside the activation of autoreactive B & T 
cells in the lymph node to illicit an autoimmune adaptive response (Pollard et al., 2018). Hg 
may also contribute to autoreactive B cell clone survival as it has been shown to disrupt B 
cell receptor signalling in immature B cells by targeting the tyrosine kinase protein, Lyn (Gill 
et al., 2017). Furthermore, disruption of BCR signalling mechanisms in immature B cells may 
disrupt negative selection of self-reactive clones and Ig class switching resulting in the loss 
of self-tolerance and the production of autoreactive B cells (Gill et al., 2017). 
 
In the current study, higher Y19Hg was significantly associated with lower IgM which may 
suggest an alteration in class switching. IgM is the first antibody to respond to an antigen or 
self-antigen and is involved in enhanced antibody response and activation of the 
complement cascade resulting in the inflammatory response. IgM plays a regulatory role in 
subsequent immune response development, thereby accelerating the production of high-
affinity IgG. Lower IgM has been associated with decreased T helper activity, increased 
isotype-specific suppressor T cell activity, and intrinsic B cell defects (Louis & Gupta, 2014). 
The association between lower IgM and higher Hg in this study could be indicative of a 
dysfunctional B cell activity frequently reported with exposure to Hg. Reduced concentrations 
of IgM have been associated with clinical disorders, including autoimmune diseases such as 
celiac disease and systemic lupus erythematosus (Manson et al., 2005; Yel et al., 2009). 
Class switching can be influenced by the cytokines available in the inflammatory milieu of 
the B-cell and the noted increased IL-10 in the Y19Hg cohort could potentially contribute to 
increased class switching from IgM to other Ig subtypes (Tangye et al. 2002). Y19Hg was 
found to be significantly associated with higher CRP, IL-10 and a lower TNFα:IL-10. In 
normal healthy adults, such as this cohort, liver production of the acute phase protein CRP 
forms part of the innate immune response, for example Hg induced DAMPs (Pollard et al, 
2018), which would be accompanied by a regulatory anti-inflammatory response via IL-10 
induction and thereby suppressing TNF-α. IL-10 is associated with non-cell mediated 
immunity where IL-10 functions as a potent B cell stimulator that enhances activation, 
proliferation, and differentiation of B cells and may have a role in autoimmune disease 
through opposing the cellular mediated inflammatory Th17 response (Jorg et al., 2016). 
There is some evidence indicating that the anti-inflammatory actions of IL-10 are defective in 
autoimmune conditions with a noted increased IL-10 concentrations alongside reduced IL-10 
receptor expression (Tournoy et al., 2000; Wang et al., 2017). In autoimmunity, elevated IL-
10 has the potential to result in the persistent activation of autoreactive B cells and therefore 
exacerbate autoimmune disease where the normal immunoregulatory function of IL-10 is 
defective (Peng et al., 2013).  
A recent examination of the Nutrition Cohort 2 (NC2) from the SCDS found that increasing 
MeHg was associated with decreasing Th1:Th2 (McSorley et al., 2018). Hg modulation of 
cytokine and antibody responses may affect an individual’s susceptibility to autoimmune type 
disease and also significantly alter host-pathogen interactions increasing susceptibility to 
infectious disease (Gardner et al., 2010). Interestingly, at 19 years the n-3 LCPUFA were 
found to be associated with decreased CRP, INF-γ, TNFα, IL6, IL10 and with a higher 
TNFα:IL-10 ratio suggesting a regulatory effect on the immune system. Therefore, it is 
speculated where individuals are exposed to MeHg from fish consumption, the co-
consumption of n-3 LCPUFA will prevent chronic inflammation and associated disease.  A 
large observation study in Italy also reported that lower n-3 PUFA was associated with 
higher CRP and that higher n-3 PUFA was associated with lower IL-6, TNF-α and CRP 
(Ferrucci et al., 2006). These results are supported by previous studies that have shown n-3 
LCPUFA to have anti-inflammatory properties associated with reduced biomarkers of 
inflammation (Rangel-Huerta et al., 2012, Pischon et al., 2003; Ferrucci et al., 2006; Calder 
2015). Furthermore, interventions with n-3 LCPUFA have been shown to reduce disease 
activity and disease progression in a number of inflammatory conditions including 
autoimmune disease (Miles & Calder, 2012, Calder, 2013).  
A strength of this research is the sizeable cohort who are high consumers of fish, have a 
wide range of hair MeHg (0.54 to 52.08 ppm) and a good status of n-3 LCPUFA as indicated 
by the low n6:n3 ratio. This longitudinal cohort has a low dropout rate and is well 
characterised across numerous timepoints including prenatally. The methods used in this 
study to analyse MeHg exposure, PUFA status and markers of autoimmunity are considered 
to be highly sensitive in order to give the most precise results. Limitations of this study 
include its cross-sectional analysis and like all observational epidemiological studies no 
cause and effect can be determined. The analyses of this study focused on MeHg exposure 
and within the Seychelles it is believed that some 80% of hair THg is MeHg (Davidson et al., 
2004); however, this may vary among other populations (Ou et al., 2014). Future studies 
should consider speciation of hair Hg or the use of Hg isotope ratios in hair in addition to 
total Hg concentrations to better assess exposure from fish derived MeHg (Sherman et al., 
2015). Genetic differences within individuals with respect to susceptibility to mercury-induced 
immune dysfunction (Gardner et al., 2010) may explain differences in ANA concentrations 
within this and other cohorts. It is also important to remember that although ANA are used in 
the diagnosis and management of autoimmune disease their identification is not always 
associated with clinical disease and interpretation must be cautious. It would be important to 
also consider additional ANAs which have been previously linked with Hg exposure such as 
anti-fibrillarin autoantibodies and anti-glomerular basement membrane (Yang et al., 2001). 
Furthermore, blood samples were stored for circa 10 years before analyses which could 
affect cytokine measurements (Zhou et al., 2010) and in part may explain the large number 
below the LOD and thereby reducing the percentage of positivity.  
In summary, MeHg exposure at 19 years was associated with higher ANA and lower IgM but 
only following adjustment for LCPUFA which may suggest immune dysregulation. Total n-3 
LCPUFA was associated with lower markers of inflammation. This study has global 
relevance given the importance of fish consumption as a source of protein and nutrition and 
that the global consumption of fish has reached an all-time high (FAO, 2018). Nevertheless, 
the clinical significance of these findings is unclear and further research is warranted to 
determine if these associations precede autoimmune disease development.  
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Table 1: Participant characteristics (n=497) 




Waist circumference (cm) 490 75.86 10.48 52-118.20 
Maternal hair MeHg (ppm) 497 6.84 4.55    0.54-26.73 
Y19 hair MeHg (ppm) 448 10.23 6.02 0.42-52.08 
Weighted average hair MeHg 
(ppm) 368 7.46 2.82 2.28-20.32 
AntiCombined ANA (% >LOD) 473 56 
 
 
IgA (g/L) 471 1.84 0.61 0.37-3.88 
IgG (g/L) 471 13.19 2.46 7.52-23.08 
IgM (g/L) 471 1.23 0.62 0.26-4.48 
Fish consumption (meals/week) 217 7.22 3.66 0-29 
n-3 LCPUFA (mg/ml) 491 0.04 0.02 0.01-0.11 
n-6 LCPUFA (mg/ml) 491 0.15 0.04 0.02-0.55 
n-6:n-3 LCPUFA 491 3.81 1.97 0.96-17.73 
MeHg, methylmercury; Y19, year 19; ppm, parts per million; ANA, antinuclear antibody; 








Table 2. Main effect models reporting covariate-adjusted associations between methylmercury (MeHg) exposure and 
antinuclear antibodies (ANA) and immunoglubulins (Ig) and inflammatory markers with and without adjustment for long 





combined1 Unadjusted  0.010 (0.031,  0.051) p=0.637  
  Adjusted for n-3 LCPUFA, n-6 
LCPUFA 
 0.017 (0.028,  0.062) p=0.472 0.036 ( 0.001,  0.073) p=0.051  
  Adjusted for n-3:n-6 LCPUFA  0.019 (0.025,  0.064) p=0.395 0.036 ( 0.001,  0.073) p=0.049 
Anti-dsDNA Unadjusted 0.002 (0.045,  0.039) p=0.909  
  
Adjusted for n-3 LCPUFA, n-6 
LCPUFA 
 0.007 (0.039,  0.053) p=0.750 0.010 (0.026,  0.046) p=0.565  
  
Adjusted for n-3:n-6 LCPUFA  0.005 (0.041,  0.050) p=0.826 0.010 (0.026,  0.046) p=0.570  
Anti-dsDNA2 Unadjusted 0.002 (‐0.030, 0.034) p=0.908 
 
  
Adjusted for n-3 LCPUFA, n-6 
LCPUFA ‐0.004 (‐0.040, 0.031) p=0.810 ‐0.010 (‐0.037, 0.017) p=0.467 
  
Adjusted for n-3:n-6 LCPUFA ‐0.002 (‐0.037, 0.033) p=0.905 ‐0.010 (‐0.037, 0.017) p=0.472 
Anti-RNP A Unadjusted  0.001 (0.045,  0.046) p=0.950  
  
Adjusted for n-3 LCPUFA, n-6 
LCPUFA 
0.001 (0.052,  0.048) p=0.969 
0.002 (0.043,  0.036) p=0.921 
  
Adjusted for n-3:n-6 LCPUFA  0.009 (0.041,  0.057) p=0.733 0.001 (0.041,  0.037) p=0.960  
Anti-RNP A2 Unadjusted ‐0.054 (‐0.806, 0.699) p=0.888 
 
  
Adjusted for n-3 LCPUFA, n-6 
LCPUFA ‐0.015 (‐0.827, 0.797) p=0.971 ‐0.003 (‐0.625, 0.619) p=0.993 
  
Adjusted for n-3:n-6 LCPUFA ‐0.154 (‐0.960, 0.652) p=0.708 ‐0.014 (‐0.639, 0.611) p=0.964 
IgG Unadjusted 0.001 (0.005,  0.002) p=0.435 
 
  
Adjusted for n-3 LCPUFA, n-6 




Adjusted for n-3:n-6 LCPUFA 0.002 (0.006,  0.002) p=0.261 0.001 (0.004,  0.002) p=0.639  
IgM Unadjusted  0.003 (0.006,  0.012) p=0.459 
 
  Adjusted for n-3 LCPUFA, n-6 
LCPUFA 
 0.002 (0.008,  0.011) p=0.714 0.009 (0.016, 0.002) 
p=0.016 
  Adjusted for n-3:n-6 LCPUFA  0.003 (0.007,  0.012) p=0.557 0.009 (0.016, 0.001) p=0.018 
IgA Unadjusted  0.004 (0.003,  0.011) p=0.274  
  Adjusted for n-3 LCPUFA, n-6 
LCPUFA 
 0.004 (0.004,  0.011) p=0.356 0.002 (0.008,  0.004) p=0.569  
  Adjusted for n-3:n-6 LCPUFA  0.004 (0.004,  0.011) p=0.342 0.002 (0.008,  0.004) p=0.562  
Il-1 beta Unadjusted ‐0.002 (‐0.007,  0.002) p=0.321 
 
  
Adjusted for n‐3 LCPUFA, n‐6 LCPUFA ‐0.003 (‐0.008,  0.002) p=0.241 0.002 (‐0.002,  0.006) p=0.307  
  
Adjusted for n‐3:n‐6 LCPUFA ‐0.003 (‐0.008,  0.002) p=0.283 0.002 (‐0.002,  0.006) p=0.303  
IL-2 Unadjusted ‐0.000 (‐0.003,  0.003) p=0.951  
  
Adjusted for n‐3 LCPUFA, n‐6 LCPUFA ‐0.000 (‐0.004,  0.003) p=0.865 ‐0.000 (‐0.003,  0.003) p=0.994  
  
Adjusted for n‐3:n‐6 LCPUFA ‐0.000 (‐0.004,  0.003) p=0.938 0.000 (‐0.003,  0.003) p=0.985  
IL-6 Unadjusted  0.014 (‐0.007,  0.036) p=0.199  
  
Adjusted for n‐3 LCPUFA, n‐6 LCPUFA ‐0.000 (‐0.023,  0.022) p=0.970 0.007 (‐0.010,  0.025) p=0.411  
  
Adjusted for n‐3:n‐6 LCPUFA  0.008 (‐0.015,  0.031) p=0.485 0.007 (‐0.010,  0.025) p=0.412  
IL-10 Unadjusted  0.011 (‐0.006,  0.028) p=0.200 
 
  
Adjusted for n‐3 LCPUFA, n‐6 LCPUFA  0.001 (‐0.018,  0.019) p=0.937 0.016 ( 0.002,  0.030) p=0.027 
  
Adjusted for n‐3:n‐6 LCPUFA  0.006 (‐0.012,  0.025) p=0.514 0.016 ( 0.002,  0.031) p=0.028  
INF-γ Unadjusted  0.001 (‐0.018,  0.020) p=0.902 
 
  
Adjusted for n‐3 LCPUFA, n‐6 LCPUFA ‐0.008 (‐0.029,  0.013) p=0.443 0.013 (‐0.004,  0.029) p=0.125 
  
Adjusted for n‐3:n‐6 LCPUFA ‐0.002 (‐0.023,  0.020) p=0.888 0.013 (‐0.003,  0.030) p=0.118 
TNF-α Unadjusted ‐0.000 (‐0.008,  0.008) p=0.995  
  
Adjusted for n‐3 LCPUFA, n‐6 LCPUFA ‐0.005 (‐0.014,  0.004) p=0.279 0.000 (‐0.007,  0.007) p=0.958  
  
Adjusted for n‐3:n‐6 LCPUFA ‐0.003 (‐0.012,  0.006) p=0.555 0.000 (‐0.007,  0.007) p=0.947  
CRP Unadjusted ‐0.009 (‐0.038,  0.021) p=0.564  
  




Adjusted for n‐3:n‐6 LCPUFA ‐0.010 (‐0.040,  0.020) p=0.517 0.031 ( 0.007,  0.054) p=0.011 
TNH-α: IL10 
ratio Unadjusted 
‐0.011 (‐0.024,  0.002) p=0.091 
 
  
Adjusted for n‐3 LCPUFA, n‐6 LCPUFA ‐0.006 (‐0.020,  0.009) p=0.436 ‐0.016 (‐0.027, ‐0.005) p=0.005 
  
Adjusted for n‐3:n‐6 LCPUFA ‐0.009 (‐0.023,  0.005) p=0.223 ‐0.016 (‐0.027, ‐0.005) p=0.005 
Data presented as odds ration (95% confidence interval) p value. All values are log transformed.  
MatHg, prenatal methylmercury exposure; Y19Hg, year 19 concurrent MeHg exposure 
Unadjusted: controlled for sex of child, maternal SES, maternal age and MatHg.  
 
Adjusted for n-3 LCPUFA, n-6 LCPUFA: controlled for sex of child, waist circumference (WC),  MatHg and Y19Hg.  
Adjusted for n-6:n-3 LCPUFA: controlled for sex of child, WC, MatHg and Y19Hg.   
1ANA combined: within or above reference range for any of the 13 measured ANA 2 Anti-dsDNA and anti-RNP A were analyzed as dichotomous 
(<LOD or LOD+)  
ANA; antinuclear antibody, dsDNA; double stranded DNA, RNP A; ribonuclear protein A,  Ig; immuoglubulin, IL; interleukin, CRP; C reactive 














Table 3. Associations between n-3  long chain polyunsaturated fatty acids (LCPUFA), n-6 LCPUFA and the n-6:n-3 
LCPUFA ratio with immune markers controlling for maternal methylmercury (MatHg). 
  n-3 PUFA n-6 PUFA n6:n3 ratio 
ANA combined1 1.148 (15.030, 12.714) p=0.871 2.380 (7.166, 2.128) p=0.311 0.021 (0.125, 0.083) p=0.690 
Anti dsDNA 9.343 (4.888, 23.685) p=0.198 1.019 (5.966, 3.637) p=0.676 0.059 (0.175, 0.049) p=0.299 
Anti RNP A 20.355 (36.893, 4.336) p=0.014 1.442 (6.652, 3.393) p=0.571 0.075 (0.035, 0.185) p=0.173 
CRP 13.805 (23.155, 4.456) p=0.004 0.451 (2.627, 3.529) p=0.774 0.091 ( 0.022, 0.161) p=0.010 
INF-γ 14.654 (21.098, 8.211) p=0.000 1.559 (3.680, 0.563) p=0.149 0.054 ( 0.005, 0.103) p=0.030 
IgA 0.221 (2.586, 2.145) p=0.855 0.058 (0.824, 0.708) p=0.882 0.003 (0.015, 0.020) p=0.753 
IgG 0.805 (2.031, 0.420) p=0.197 0.299 (0.696, 0.097) p=0.139 0.000 (0.009, 0.009) p=0.963 
IgM 1.215 (4.156, 1.726) p=0.417 0.423 (1.376, 0.529) p=0.383 0.007 (0.029, 0.015) p=0.533 
IL-1 0.236 (1.387, 1.859) p=0.775 0.377 (0.912, 0.157) p=0.166 0.005 (0.017, 0.007) p=0.419 
IL-10 18.461 (24.125, 12.797) p<0.001 0.560 (1.305, 2.425) p=0.556 0.110 ( 0.067, 0.153) p<0.001 
IL-2 0.007 (1.125, 1.138) p=0.991 0.133 (0.506, 0.239) p=0.482 0.003 (0.011, 0.006) p=0.509 
IL-6 
23.841 (30.760, 16.921) 
p<0.001 1.026 (3.304, 1.252) p=0.377 0.130 ( 0.077, 0.183) p<0.001 
TNF-α 7.541 (10.275, 4.808) p<0.001 0.196 (0.704, 1.096) p=0.668 0.045 ( 0.024, 0.065) p<0.001 
TNF-α:IL-10 10.920 ( 6.549, 15.291) p<0.001 0.363 (1.802, 1.076) p=0.620 0.065 (0.098, 0.032) p<0.001 
Anti dsDNA2 7.354 (18.227, 3.518) p=0.184 0.523 (2.990, 4.035) p=0.770 0.041 (0.040, 0.122) p=0.322 
Anti RNA2 295.607 (44.831, 546.383) p=0.021 28.539 (52.488, 109.565) p=0.489 1.085 (2.963, 0.793) p=0.257 
Models controlled for sex of child, maternal SES, maternal age and MatHg.  
 
ANA; antinuclear antibody, dsDNA; double stranded DNA, RNP A; ribonuclear protein A, CRP; C reactive protein, INF-γ; interferon 
gamma, Ig; immuoglubulin, IL; interleukin, TNF-α; tumour necrosis factor-alpha, 
1, ANA combined: within or above reference range for any of the 13 measured ANA 
2, Anti-dsDNA and anti-RNP A were analyzed as dichotomous (<LOD or LOD+)  
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1. Concurrent methylmercury (MeHg) exposure is associated with a higher odds 
ratio of being positive for the presence of an antinuclear antibody (ANA) and a 
lower IgM but only following adjustment of n-3 long chain polyunsaturated 
fatty acids (LCPUFA) or the n-6:n-3 LCPUFA ratio.  
2. Prenatal methylmercury exposure was not associated with ANA or any 
biomarker of inflammation at age 19 years. 
3. N-3 LCPUFA were associated with lower markers of inflammation whereas a 
higher n-6:n-3 LCPUFA ratio was associated with higher biomarkers of 
inflammation. 
4. Further research is required to determine if MeHg exposure at an older age is 
associated with the onset of autoimmune disease.  
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